WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)

WITHUS PHARMACEUTICAL Co.,LTD. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020
Market Capitalization	93,999	128,366	123,616	138,481	189,477	-
Market Cap Growth	7.36%	3.84%	-10.73%	-26.91%	-	-
Enterprise Value	106,828	130,632	113,324	119,353	163,763	-
Last Close Price	7120.00	9730.00	9270.64	10388.65	14147.75	-
PE Ratio	12.29	16.13	49.31	32.16	17.60	-
PS Ratio	0.96	1.60	1.91	2.41	3.55	-
PB Ratio	1.04	1.42	1.49	1.71	2.46	-
P/FCF Ratio	-13.94	-10.66	-12.42	102.25	-42.54	-
P/OCF Ratio	-51.09	-103.79	22.98	17.26	234.06	-
EV/Sales Ratio	1.09	1.63	1.75	2.08	3.07	-
EV/EBITDA Ratio	8.81	12.15	16.60	18.69	17.79	-
EV/EBIT Ratio	12.36	16.52	23.23	24.43	22.65	-
EV/FCF Ratio	-14.72	-10.85	-11.39	88.13	-36.76	-
Debt / Equity Ratio	0.24	0.22	0.26	0.29	0.22	0.20
Debt / EBITDA Ratio	1.77	1.86	3.14	3.62	1.87	1.39
Debt / FCF Ratio	-2.96	-1.66	-2.16	17.06	-3.87	4.76
Asset Turnover	0.78	0.64	0.54	0.51	-	0.57
Inventory Turnover	2.67	2.52	3.07	2.98	-	3.12
Quick Ratio	1.13	1.20	1.74	2.55	2.94	2.70
Current Ratio	1.80	1.88	2.32	3.19	3.64	3.04
Return on Equity (ROE)	8.70%	9.18%	3.02%	5.40%	-	12.44%
Return on Assets (ROA)	4.31%	3.95%	2.56%	2.71%	-	6.64%
Return on Capital (ROIC)	5.01%	4.60%	2.92%	3.08%	-	7.80%
Earnings Yield	8.14%	6.20%	2.01%	3.08%	3.51%	-
FCF Yield	-7.72%	-9.38%	-8.05%	0.98%	-2.35%	-
Payout Ratio	17.24%	-	25.53%	9.90%	54.19%	-
Buyback Yield / Dilution	-0.20%	-0.03%	0.10%	-59.55%	-6.63%	-0.15%
Total Shareholder Return	-0.20%	-0.03%	0.10%	-59.55%	-6.63%	-0.15%

Source: S&P Capital IQ. Standard template. Financial Sources.